Clinical Trial Update: A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating three doses of fozivudine added to a standard zidovudine-based ART regimen for sustained virologic suppression (HIV-1 RNA <50 copies/mL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fozivudine (fozivudine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: Michael Hoelscher | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED